|   |   |
   Home  |  Site Map  |  Contact Us  
  
COMPANY

Over the next decade, nanotechnology has the potential to influence virtually every aspect of our lives, including our energy, food, water, buildings, and medicines. However, in order to realize this broad potential - robust, cost-effective, regulatory-friendly manufacturing technologies will be required. Through its novel technology platform and expansive intellectual property, Liquidia is poised to be a leader in the development of nanotechnology-based healthcare products and a catalyst for the growth anticipated across this industry.

By leveraging fabrication techniques from the semiconductor industry, Liquidia has the ability to rapidly design and manufacture precisely engineered particles of virtually any size, shape, or composition. Learn more >

ANNOUNCEMENTS

September 10, 2014
Liquidia Announces Formation of Lq3 Pharmaceuticals, an Oral Health Company Details

August 13, 2014
Liquidia Technologies to Present New Data Supporting the Role of Particle Size and Shape in Vaccine Development Details

May 1, 2014
Liquidia Technologies to Present New Data on Next-Generation Multivalent Pneumococcal Vaccine Details

April 8, 2014
Liquidia Technologies Hosts NC COIN Show & Tell Event Details

March 11, 2014
Liquidia Technologies Presents New Data on Next-Generation Pneumococcal Vaccines Details


RECENT NEWS


September 15, 2014
Xconomy: Raleigh-Durham Roundup: Liquidia, TrueBridge, Citrix, & More Details

September 10, 2014
TBJ: Durham's Liquidia spins out second company; raises $10M from Canaan Partners Details

May 22, 2014
Liquidia Technologies Featured at RTRP 2014 State of Region Event Details

March 3, 2014
TBJ: Liquidia Technologies a 2014 Health Care Hero Finalist Details

November 13, 2013
Fierce Drug Delivery: : Sustained-Release Glaucoma Treatment nets $25M for Liquidia's Envisia Details


© 2014 Liquidia Technologies | PO Box 110085 | Research Triangle Park, NC 27709 | P.919.328.4400 | F.919.328.4402 | email: info@liquidia.com